Coal India, PB Fintech, Sun Pharma, Mankind Pharma, and Lupin among top stocks to track today
Stocks to watch: PB Fintech's promoter Tencent Cloud Europe BV has reduced the stake to 6.28 per cent from 8.37 per cent.
Stocks to watch, May 31, 2023: Indian equities are expected to see a cautious start on May 31, Wednesday. Asia's stock markets slid toward a second month of losses in a row on Wednesday, and even the glittering Nikkei paused, as weak Chinese factory activity fed growing doubts about the post-pandemic recovery in the world's second-biggest economy. At 08:27 AM, the Nifty futures on the Singapore Exchange (SGX) traded at 18,658, down 72 points, or 0.38 per cent.
Let's take a look at the top stocks that may remain in focus today:
Coal India: The company has increased the prices of its high-grade coal by 8 per cent. This is the first time since 2018 that the country’s largest coal miner has revised its coal prices, which will be applicable to all its subsidiaries as well.
PB Fintech: The parent company of Policybazaar's promoter Tencent Cloud Europe BV has reduced the stake to 6.28 per cent from 8.37 per cent.
Mankind Pharma: The newly-listed company on Tuesday reported a 50 per cent year-on-year growth in consolidated net profit at Rs 285 crore for the quarter ended March 31, 2023. It reported a consolidated net profit of Rs 190 crore in the year-ago period.
Sona BLW Precision: The company's promoter entity, as per news reports, Aureus Investment is likely to sell up to a 3.25 per cent stake in automotive technology firm Sona BLW Precision Forgings (Sona Comstar) via a block deal today.
Indiabulls Real Estate: For the fourth quarter, the company's net loss widened to Rs 376 crore as against a net loss of Rs 61 crore during the corresponding quarter of the previous fiscal. The revenue from operations came in at Rs 133 crore, down by 51 per cent YoY from Rs 273 crore in Q4FY22.
Lupin: The drug major on Tuesday said it has inked a strategic pact with Enzene Biosciences to launch biosimilar cetuximab in India for the treatment of head and neck cancer.
Sun Pharma: The pharma major and Philogen SpA have entered into a licensing agreement for commercialising Philogen’s speciality cancer product, Nidlegy (Daromun) in Europe, Australia, and New Zealand.
SBI: Shares of State Bank of India (SBI) — the country's largest lender by assets — will trade ex-dividend on Wednesday, May 31.
KRBL on May 30, Tuesday said its fourth-quarter profit jumped more than 8 per cent on strong domestic demand for its India Gate-branded basmati rice. The company's consolidated net profit rose to 1.18 billion rupees ($14.27 million) for the quarter ended March 31, from 1.09 billion rupees a year ago, it said in an exchange filing.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Looking for short term investment ideas? Analysts suggest buying these 2 stocks for potential gain; check targets
Rs 3,500 Monthly SIP for 35 years vs Rs 35,000 Monthly SIP for 16 Years: Which can give you higher corpus in long term? See calculations
Small SIP, Big Impact: Rs 1,111 monthly SIP for 40 years, Rs 11,111 for 20 years or Rs 22,222 for 10 years, which do you think works best?
08:47 AM IST